Resolution of CD8+ lymphomatoid papulosis after surgical excision of the type AB-thymoma

American Journal of Dermatopathology

Volumn 31, Issue 5, 2009, Pages 475-479

  Souza, Aieska De ^a   Gibson, Lawrence E ^a   Wada, David A ^a   Yi, Eunhee S ^b   Medeiros, Fabiola ^b   Camilleri, Michael J ^a   El Azhary, Rokea ^a   Micallef, Ivana N ^c  

^a Departments of Dermatology   (United States)

^b Anatomic Pathology ^*

^c MAYO CLINIC   (United States)

Author keywords

Lymphomatoid; Papulosis; Thymoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CD99 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; CYTOKERATIN 19; CYTOKERATIN 7; DNA NUCLEOTIDYLEXOTRANSFERASE; FLUORODEOXYGLUCOSE F 18; GENOMIC DNA; KERATIN; LEUKOSIALIN; OSCAR KERATIN; PARAFFIN; PROTEIN P80; RANTES; T6 ANTIGEN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TIA 1 ANTIGEN; UNCLASSIFIED DRUG; CHEMOKINE; CHEMOKINE RECEPTOR; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ABDOMEN; ACANTHOSIS; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CASE REPORT; CD3+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; DERMIS; DISEASE DURATION; DNA EXTRACTION; DYSKERATOSIS; EPIDERMIS CELL; ERYTHROCYTE; EXCISION; EXTRAVASATION; FOLLOW UP; FOREARM; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KERATINOCYTE; KNEE; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; LYMPHOMATOID PAPULOSIS; MALE; MEDIASTINUM MASS; MICROSCOPE; PAPULE; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; STAINING; THIGH; THYMOMA; TISSUE NECROSIS; TYPE AB THYMOMA; ULCER; CD8+ T LYMPHOCYTE; IMMUNOLOGY; METABOLISM; MULTIPLE CANCER; PATHOLOGY; SKIN TUMOR;

AGED, 80 AND OVER; ANTIGENS, CD; BLOTTING, SOUTHERN; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMATOID PAPULOSIS; MALE; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 69849115745     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31818d0796     Document Type: Article

References (30)

1. Macaulay WL. Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol. 1968;97:23-30.
2. Sa ́nchez NP, Pittelkow MR, Muller SA, et al. The clinico-pathologic spectrum of lymphomatoid papulosis: study of 31 cases. J Am Acad Dermatol. 1983;8:81-94.
3. El-Azhary R, Gibson LE, Kurtin PJ, et al. Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies. J Am Acad Dermatol. 1994;30:210-218.
4. Basarab T, Fraser-Andrews EA, Orchad G, et al. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol. 1998;139:630-638.
5. Kadin M. Lymphomatoid papulosis and associated lymphomas: how are they related? Arch Dermatol. 1993;129:351-352.
6. Liu HL, Hoppe RT, Kohler S, et al. CD 30+ cutaneous lymphoprolifer-ative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49:1049-1058.
7. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000;12:3653-3661.
8. Kuo TT, Mukai K, Eimoto T, et al. Type AB thymoma. In: Travis WD, ed. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:157-158.
9. Tormoehlen LM, Pascuzzi RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am. 2008;22: 509-526.
10. Gibson LE, Muller SA. Dermatologic disorders in patients with thymoma. Acta Derm Venereol. 1987;67:351-356.
11. Durum SK. Cytokines and the immune system [Cytokine Reference Website]. April 7, 2003. Available at: http://apresslp.gvpi.net/apcyto/ lpext.dll?f=templates&fn=main-h.htm&2.0. Accessed June 25, 2008.
12. Schon MP, Zollner TM, Boehncke WH. The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. J Invest Dermatol. 2003;121: 951-962.
13. Ströbel P, Marino M, Feuchtenberger M, et al. Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. J Pathol. 2005;207:72-82.
14. Suzuki Y, Onodera H, Tago H, et al. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients. J Neuroimmunol. 2006;172:166-174.
15. Slater DN. The new World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005; 153:874-880.
16. Zelickson BD, Peters MS, Muller SA, et al. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol. 1991;25:787-796.
17. Magro CM, Crowson AN, Morrison C, et al. CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol. 2006;125: 490-501.
18. Weinstein A, Mirzabeigi M, Whitee M, et al. Lymphomatoid papulosis in an HIV positive man. AIDS Patient Care STDS. 2004;18:563-567.
19. Aoki E, Aoki M, Kono M, et al. Two cases of lymphomatoid papulosis in children. Pediatr Dermatol. 2003;20:146-149.
20. Slone SP, Martin AW, Wellhausen SR, et al. IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils. J Cutan Pathol. 2008;4:1-8.
21. Willemeze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
22. Magro CM, Nouvo G, Crowson AN. The utility of the in situ detection of T-cell receptor beta rearrangements in cutaneous T-cell-dominant infiltrates. Diagn Mol Pathol. 2003;12:133-141.
23. Yagi H, Seo N, Ohshima A, et al. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol. 2006;30: 1111-1119.
24. Yamaguchi T, Ohshima K, Karube K, et al. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Br J Dermatol. 2006;154:904-909.
25. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/ CCL17 and skin diseases. J Dermatol Sci. 2006;43:75-84.
26. Soler D, Humphreys TL, Spinola SM, et al. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood. 2003;101:1677-1682.
27. Vermeer MH, Dukers DF, Ten Berge RL, et al. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease. Mod Pathol. 2002;15:838-844.
28. Kakinuma T, Sugaya M, Nakamura K, et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol. 2003;48:23-30.
29. Lu D, Duvic M, Medeiros LJ, et al. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol. 2001;115:413-421.
30. Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol. 2005;42: 799-809.